Eli Lilly’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S. regulatory approval as it won support from an independent panel of advisers to the Food and Drug Administration.
Source link
Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers
![](https://westvirginiadigitalnews.com/wp-content/uploads/2024/06/im-76149731-1200x853.jpeg)